High Cancer Prevalence and Rise in Number of Pharmacies to Boost Growth Rate of Kinase Inhibitors Market: TMR
-
The kinase inhibitors market is prognosticated to record a CAGR of ~4 percent across the forecast period of 2019-2027 owing to the numerous growth factors
ALBANY, N.Y., Jan. 26, 2021 /PRNewswire/ The growing cancer prevalence across a variety of regions across the world may bring tremendous growth opportunities for the kinase inhibitors market during the tenure of 2019-2027. Cancer is one of the leading causes of death according to the World Health Organization (WHO). The WHO also estimates that cancer accounts for nearly 9.6 mn deaths yearly across the globe. Hence, these statistics highlight the rising need for developing efficient drugs.